Showing results 1 to 20 of 192
next >
| Issue Date | Title | Author(s) |
| 2007 | Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma | Zhang, Qlan; Ying, Jianming; Zhang, Kai; Li, Hongyu; Ng, Ka Man; Zhao, Yayuan; He, Qun; Yang, Xinyu; Xin, Dianqi; Liao, Shuen-Kuei; Tao, Qian; Jin, Jie |
| 2010 | Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage | Zhang, Qian; Ying, Jianming; Li, Jisheng; Fan, Yichao; Poon, Fan Fong; Ng, Ka Man; Tao, Qian; Jin, Jie |
| 2015 | Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer | Ye, Dingwei; Zou, Qing; Sun, Zhongquan; Sun, Yinghao; Li, Changling; Du, Chuanjun; Chen, Zhiwen; Shan, Yuxi; Huang, Yiran; Jin, Jie; Ye, Zhang Qun; Xie, Liping; Feng, Yi; De Porre, Peter; Liu, Weiping; Ye, Dingwei |
| 2015 | Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer | Ye, Dingwei; Zou, Qing; Sun, Zhongquan; Sun, Yinghao; Li, Changling; Du, Chuanjun; Chen, Zhiwen; Shan, Yuxi; Huang, Yiran; Jin, Jie; Ye, Zhang Qun; Xie, Liping; Feng, Yi; De Porre, Peter; Liu, Weiping; Ye, Dingwei |
| 2016 | Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study | Sun, Yinghao; Zou, Qing; Sun, Zhongquan; Li, Changling; Du, Chuanjun; Chen, Zhiwen; Shan, Yuxi; Huang, Yiran; Jin, Jie; Ye, Zhang Qun; Xie, Liping; Lin, Guowen; Feng, Yi; De Porre, Peter; Liu, Weiping; Ye, Dingwei |
| 2016 | Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptoms | Zhai, Kui; Yang, Zhiguang; Zhu, Xiaofei; Nyirimigabo, Eric; Mi, Yue; Wang, Yan; Liu, Qinghua; Man, Libo; Wu, Shiliang; Jin, Jie; Ji, Guangju |
| 2019 | Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8(+) T cells in benign prostatic hyperplasia | Jin, Song; Xian, Peng; Liu, Jie; Yang, Yang; Hu, Shuai; Sheng, Jindong; He, Qun; Yu, Wei; Han, Wenke; Jin, Jie; Peng, Jing |
| Jun-2020 | Acute kidney injury in solitary kidney patients after partial nephrectomy: incidence, risk factors and prediction | Zhu, Kun; Song, Haifeng; Zhang, Zhenan; Ma, Binglei; Bao, Xiaoyuan; Zhang, Qian; Jin, Jie |
| Jun-2021 | Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study | Dou, Xuelin; Zheng, Fangyuan; Zhang, Liqiang; Jin, Jie; Zhang, Yanli; Liu, Bingcheng; Meng, Li; Zhu, Xiaofan; Lu, Zesheng; Jia, Yueping; Liu, Huilan; Lin, Hai; Zhou, Li; Zhao, Xielan; Yang, Wei; Sun, Hui; Qian, Sixuan; Ma, Hongxia; Du, Xin; Bai, Qingxian; Xu, Na; Meng, Fanjun; Jia, Zhilin; Di, Haixia; Zhang, Leping; Jiang, Qian |
| 2015 | Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients | Yang, Xinyu; Xi, Chenguang; Jin, Jie; Zhou, Liqun; Su, Jinwei; Liu, Libo; Liu, Yuli |
| 2007 | Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta 1 in prostate tissue of spontaneously hypertensive rats | Yu, Wei; Zhao, Ya-Yuan; Zhang, Zhi-Wen; Guo, Ying-Lu; Jin, Jie |
| Sep-2022 | Apatinib enhances chemosensitivity of ABT-199 in diffuse large B-cell lymphoma | Shi, Yuanfei; Ye, Jing; Shen, Huafei; Xu, Yi; Wan, Rui; Ye, Xiujin; Jin, Jie; Xie, Wanzhuo |
| 2016 | Association of ABO blood types and clinicopathological features of ureteral transitional cell carcinoma in a single-center in China | Huang, Haichao; Li, Xin; Jin, Jie |
| 2015 | Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study | Qin, Shukui; Bi, Feng; Jin, Jie; Cheng, Ying; Guo, Jun; Ren, Xiubao; Huang, Yiran; Tarazi, Jamal; Tang, Jie; Chen, Connie; Kim, Sinil; Ye, Dingwei |
| 2018 | Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma | Jin, Jie; Okamoto, Rumiko; Yoon, Sung-Soo; Shih, Lee-Yung; Zhu, Jun; Liu, Ting; Hong, Xiaonan; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi; Huang, Huiqiang |
| Jun-2020 | CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study | Qian, Jie-Jing; Hu, Xiaoxia; Wang, Ying; Zhang, Yi; Du, Juan; Yang, Min; Tong, Hongyan; Qian, Wen-Bin; Wei, Juying; Yu, Wenjun; Lou, Yin-Jun; Mao, Liping; Meng, Hai Tao; You, Liang-Shun; Wang, Libing; Li, Xia; Huang, Xin; Cao, Li-Hong; Zhao, Jian-Zhi; Yan, Xiao Yan; Chen, Yu-Bao; Chen, Yu; Zhang, Su-Jiang; Jin, Jie; Hu, Jiong; Zhu, Hong-Hu |
| 2012 | A Case of Central Metanephric Adenoma Successfully Treated With Laparoscopic Nephron-sparing Surgery | Xu, Ben; Zhang, Qian; Jin, Jie |
| 2017 | Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China | Zhang, Xiaohui; Hu, Jiong; Hu, Yu; Huang, He; Jin, Jie; Li, Juan; Liu, Qifa; Shao, Zonghong; Wang, Jianxiang; Wang, Quanshun; Wu, Depei; Huang, Xiaojun |
| 2017 | CD8+T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway | Yang, Yang; Hu, Shuai; Liu, Jie; Cui, Yun; Fan, Yu; Lv, Tianjing; Liu, Libo; Li, Jun; He, Qun; Han, Wenke; Yu, Wei; Sun, Yin; Jin, Jie |
| 2016 | Characteristics of Chinese patients with advanced prostate cancer: A muliticentre, non-interventional, observational, prospective, registry study of docetaxel. | He, Dalin; Sun, Zhongquan; Guo, Jianming; Zhang, Zhigen; Shan, Yuxi; Ma, Lulin; Li, Hanzhong; Jin, Jie; Huang, Yiran; Xiao, Jiaquan; Wei, Qiang; Ye, Dingwei |
